Literature DB >> 22806619

Evaluation of the trade-offs encountered in planning and treating locally advanced head and neck cancer: intensity-modulated radiation therapy vs dual-arc volumetric-modulated arc therapy.

M Oliver1, D McConnell, M Romani, A McAllister, A Pearce, A Andronowski, X Wang, K Leszczynski.   

Abstract

OBJECTIVE: The primary purpose of this study was to assess the practical trade-offs between intensity-modulated radiation therapy (IMRT) and dual-arc volumetric-modulated arc therapy (DA-VMAT) for locally advanced head and neck cancer (HNC).
METHODS: For 15 locally advanced HNC data sets, nine-field step-and-shoot IMRT plans and two full-rotation DA-VMAT treatment plans were created in the Pinnacle(3) v. 9.0 (Philips Medical Systems, Fitchburg, WI) treatment planning environment and then delivered on a Clinac iX (Varian Medical Systems, Palo Alto, CA) to a cylindrical detector array. The treatment planning goals were organised into four groups based on their importance: (1) spinal cord, brainstem, optical structures; (2) planning target volumes; (3) parotids, mandible, larynx and brachial plexus; and (4) normal tissues.
RESULTS: Compared with IMRT, DA-VMAT plans were of equal plan quality (p>0.05 for each group), able to be delivered in a shorter time (3.1 min vs 8.3 min, p<0.0001), delivered fewer monitor units (on average 28% fewer, p<0.0001) and produced similar delivery accuracy (p>0.05 at γ(2%/2mm) and γ(3%/3mm)). However, the VMAT plans took more planning time (28.9 min vs 7.7 min per cycle, p<0.0001) and required more data for a three-dimensional dose (20 times more, p<0.0001).
CONCLUSIONS: Nine-field step-and-shoot IMRT and DA-VMAT are both capable of meeting the majority of planning goals for locally advanced HNC. The main trade-offs between the techniques are shorter treatment time for DA-VMAT but longer planning time and the additional resources required for implementation of a new technology. Based on this study, our clinic has incorporated DA-VMAT for locally advanced HNC. ADVANCES IN KNOWLEDGE: DA-VMAT is a suitable alternative to IMRT for locally advanced HNC.

Entities:  

Mesh:

Year:  2012        PMID: 22806619      PMCID: PMC3611711          DOI: 10.1259/bjr/26344684

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  15 in total

Review 1.  A review of the clinical evidence for intensity-modulated radiotherapy.

Authors:  J Staffurth
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-07-31       Impact factor: 4.126

2.  Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT.

Authors:  Eugenio Vanetti; Alessandro Clivio; Giorgia Nicolini; Antonella Fogliata; Sarbani Ghosh-Laskar; Jai Prakash Agarwal; Ritu Raj Upreti; Ashwini Budrukkar; Vedang Murthy; Deepak Dattatray Deshpande; Shyam Kishore Shrivastava; Ketayun Ardeshir Dinshaw; Luca Cozzi
Journal:  Radiother Oncol       Date:  2009-01-20       Impact factor: 6.280

3.  When is better best? A multiobjective perspective.

Authors:  Mark H Phillips; Clay Holdsworth
Journal:  Med Phys       Date:  2011-03       Impact factor: 4.071

4.  Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques.

Authors:  K S Chao; N Majhail; C J Huang; J R Simpson; C A Perez; B Haughey; G Spector
Journal:  Radiother Oncol       Date:  2001-12       Impact factor: 6.280

5.  RapidArc planning and delivery in patients with locally advanced head-and-neck cancer undergoing chemoradiotherapy.

Authors:  Patricia Doornaert; Wilko F A R Verbakel; Michael Bieker; Ben J Slotman; Suresh Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-24       Impact factor: 7.038

6.  A comparison of several modulated radiotherapy techniques for head and neck cancer and dosimetric validation of VMAT.

Authors:  Florian Stieler; Dirk Wolff; Heike Schmid; Grit Welzel; Frederik Wenz; Frank Lohr
Journal:  Radiother Oncol       Date:  2011-09-30       Impact factor: 6.280

7.  Volumetric-modulated arc therapy in head and neck radiotherapy: a planning comparison using simultaneous integrated boost for nasopharynx and oropharynx carcinoma.

Authors:  M Johnston; S Clifford; R Bromley; M Back; L Oliver; T Eade
Journal:  Clin Oncol (R Coll Radiol)       Date:  2011-03-11       Impact factor: 4.126

Review 8.  Radiation-induced second cancers: the impact of 3D-CRT and IMRT.

Authors:  Eric J Hall; Cheng-Shie Wuu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-05-01       Impact factor: 7.038

9.  Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study.

Authors:  Wilko F A R Verbakel; Johan P Cuijpers; Daan Hoffmans; Michael Bieker; Ben J Slotman; Suresh Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-05-01       Impact factor: 7.038

10.  IMRT in oral cavity cancer.

Authors:  Gabriela Studer; Roger A Zwahlen; Klaus W Graetz; Bernard J Davis; Christoph Glanzmann
Journal:  Radiat Oncol       Date:  2007-04-12       Impact factor: 3.481

View more
  4 in total

1.  Advantage of 3D volumetric dosemeter in delivery quality assurance of dynamic arc therapy: comparison of pencil beam and Monte Carlo calculations.

Authors:  H-J Shin; J H Song; J-Y Jung; Y-K Kwak; C S Kay; Y-N Kang; B O Choi; H S Jang; S H Son
Journal:  Br J Radiol       Date:  2013-11-14       Impact factor: 3.039

2.  A feedback constraint optimization method for intensity-modulated radiation therapy of nasopharyngeal carcinoma.

Authors:  Yongwu Li; Xiaonan Sun; Q I Wang; Qinxuan Zhou; Benxing Gu; Guozhi Shi; Dongliang Jiang
Journal:  Oncol Lett       Date:  2015-07-23       Impact factor: 2.967

Review 3.  Clinical utility of RapidArc™ radiotherapy technology.

Authors:  Erminia Infusino
Journal:  Cancer Manag Res       Date:  2015-11-12       Impact factor: 3.989

4.  A nomogram for predicting late radiation-induced xerostomia among locoregionally advanced nasopharyngeal carcinoma in intensity modulated radiation therapy era.

Authors:  Kaixuan Yang; Wenji Xie; Xiangbin Zhang; Yu Wang; Arthur Shou; Qiang Wang; Jiangfang Tian; Jiangping Yang; Guangjun Li
Journal:  Aging (Albany NY)       Date:  2021-07-19       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.